Connection
Chad Morris to Nicotinic Agonists
This is a "connection" page, showing publications Chad Morris has written about Nicotinic Agonists.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.854 |
|
|
|
-
Morris CD, Garver-Apgar CE. Nicotine and Opioids: a Call for Co-treatment as the Standard of Care. J Behav Health Serv Res. 2020 10; 47(4):601-613.
Score: 0.660
-
Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013 Sep 17; 159(6):390-400.
Score: 0.101
-
Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012 May; 73(5):654-60.
Score: 0.092